verzenios
eli lilly nederland b.v. - abemaciclib - néoplasmes du sein - agents antinéoplasiques - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
skinvisible antiseptic skin cleanser lotion
skinvisible pharmaceuticals inc - triclosan - lotion - 1% - triclosan 1% - miscellaneous local anti-infectives
skinvisible chlorhexidine formula hand sanitizer lotion
skinvisible pharmaceuticals inc - gluconate de chlorhexidine - lotion - 2.25% - gluconate de chlorhexidine 2.25% - miscellaneous local anti-infectives
verzenios 50 mg comprimés filmés
eli lilly (suisse) sa - abemaciclibum - comprimés filmés - abemaciclibum 50 mg, excipiens pro pilote de obducto. - cancer du sein précoce - synthetika
verzenios 100 mg comprimés filmés
eli lilly (suisse) sa - abemaciclibum - comprimés filmés - abemaciclibum 100 mg, excipiens pro pilote de obducto. - cancer du sein précoce - synthetika
verzenios 150 mg comprimés filmés
eli lilly (suisse) sa - abemaciclibum - comprimés filmés - abemaciclibum 150 mg, excipiens pro pilote de obducto. - cancer du sein précoce - synthetika
verzenios 200 mg comprimés filmés
eli lilly (suisse) sa - abemaciclibum - comprimés filmés - abemaciclibum 200 mg, excipiens pro pilote de obducto. - cancer du sein précoce - synthetika
nicorette invisi patch 10 mg dispositif transderm. sachet
johnson & johnson consumer sa-nv - nicotine 15,75 mg - dispositif transdermique - 10 mg - nicotine 15.75 mg - nicotine
nicorette invisi patch 15 mg dispositif transderm. sachet
johnson & johnson consumer sa-nv - nicotine 23,62 mg - dispositif transdermique - 15 mg - nicotine 23.62 mg - nicotine
nicorette invisi patch 25 mg dispositif transderm. sachet
johnson & johnson consumer sa-nv - nicotine 39,37 mg - dispositif transdermique - 25 mg - nicotine 39.37 mg - nicotine